Bacillus Subtilis Market Size, Share, Growth, and Industry Analysis, By Type (Below 100 Billion CFU/g, 100-300 Billion CFU/g, Above 300 Billion CFU/g), By Application (Feed Additives, Pesticide and Others), Regional Insights, and Forecast to 2035

• 

  Download Free Sample to learn more about this report

Bacillus Subtilis Market Overview

The global bacillus subtilis market size at USD 0.09 billion in 2025 and is projected to reach USD 0.1 billion in 2026, growing further to USD 0.19 billion by 2035 at an estimated CAGR of 7.4% from 2026 to 2035. Asia-Pacific holds leading position in bacillus subtilis market share in 2023.

Bacillus subtilis is a Gram-positive, rod-shaped bacterium that is naturally occurring and non-pathogenic. It has been used in the pharmaceutical industry for many years to produce enzymes and other products. In recent years, there has been increasing interest in using it to develop new drugs and vaccines.

It is a very versatile bacterium. It can produce a wide variety of proteins, including enzymes, antibiotics, and vaccines. It is also relatively easy to grow and manipulate in the laboratory. Another reason for the interest in Bacillus subtilis is that it is a safe bacterium. It has been used in food and beverage products for many years, and it is generally regarded as safe (GRAS) by the FDA.

KEY FINDINGS

COVID-19 Impact: Pandemic Increased the Market Demand

The global COVID-19 pandemic has been unprecedented and staggering, with the Bacillus subtilis market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden rise in CAGR is attributable to the market's growth and demand returning to pre-pandemic levels once the pandemic is over.

The COVID-19 pandemic has had a significant impact on the Bacillus subtilis market share. Demand for them in the pharmaceutical industry has increased, as the bacterium is being used to develop new drugs and vaccines. It is a Gram-positive bacterium that is naturally occurring and non-pathogenic. It has been used in the pharmaceutical industry for many years to produce enzymes and other products. In recent years, there has been increasing interest in using it to develop new drugs and vaccines. One of the reasons for this interest is that it is a very versatile bacterium. It can produce a wide variety of proteins, including enzymes, antibiotics, and vaccines. It is also relatively easy to grow and manipulate in the laboratory. Another reason for the interest in it is that it is a safe bacterium. It has been used in food and beverage products for many years, and it is generally regarded as safe (GRAS) by the FDA. This makes it a good candidate for the development of new drugs and vaccines, as there is less risk of safety concerns.

Latest Trends

The development of new strains with enhanced properties is expected to fuel the growth in the market

The development of new strains of Bacillus subtilis with enhanced properties is an active area of research. Scientists are using a variety of techniques to improve the bacterium's performance in different applications. One common approach is to genetically engineer Bacillus subtilis to express new genes or to modify existing genes. This can be done to improve the bacterium's ability to produce specific proteins, to resist antibiotics, or to survive in harsh environments. Another approach is to select naturally occurring strains of it that have desirable properties. This can be done by screening large populations of bacteria for strains that have the desired traits. The development of new strains with enhanced properties has the potential to revolutionize a wide range of industries. For example, new strains of the bacterium could be used to produce more effective antibiotics, to improve the safety of food, or to develop new bioremediation technologies.

• According to U.S. government sources, Bacillus subtilis strain QST 713 is exempt from tolerance requirements for residues in food when used properly. Approximately 85% of registered agricultural microbial products now include B. subtilis strains.
• Industrial-scale fermentation studies report Bacillus subtilis achieving cell concentrations of over 90% efficiency in large 3,000-liter bioreactors, marking significant progress in microbial production.

Download Free Sample to learn more about this report

Bacillus Subtilis Market Segmentation

By Type Analysis

According to type, the market can be segmented Below 100 Billion CFU/g, 100-300 Billion CFU/g, Above 300 Billion CFU/g.

• Below 100 Billion CFU/g: Products in this range offer moderate probiotic support, ideal for everyday gut maintenance. They gently enhance digestive balance without overwhelming the microbiome.
• 100–300 Billion CFU/g: These formulations provide robust probiotic strength, supporting stronger digestive and immune function. They are suitable for individuals seeking noticeable gut health benefits.
• Above 300 Billion CFU/g: Ultra-potent probiotics deliver maximum colony-forming units for intensive gut restoration. They are often used for targeted interventions or after significant digestive disturbances.

By Application Analysis

Based on application, the market can be divided into Feed Additives, Pesticide and Others.

• Feed Additives: Feed additives enhance animal nutrition, promoting growth, immunity, and overall health. They are carefully formulated to improve productivity while maintaining food safety standards.
• Pesticide: Pesticides protect crops from pests, diseases, and invasive species, ensuring higher yields. Responsible usage minimizes environmental impact and safeguards human and animal health.
• Others: This category includes miscellaneous substances used in agriculture, industry, or food processing that don’t fit standard classifications. They often serve specialized purposes, from preservatives to processing aids, ensuring quality and efficiency.

Driving Factors

Increasing demand for natural and organic products to foster the market growth

There is a growing demand for natural and organic products in the global market. This is due to a number of factors, including the increasing awareness of the health risks associated with synthetic chemicals, the desire to protect the environment, and the growing popularity of alternative medicine. It is a natural bacterium that has a number of health benefits. It is a probiotic, which means that it helps to maintain a healthy balance of bacteria in the gut. It also has anti-inflammatory and antioxidant properties. The increasing demand for natural and organic products is driving the growth of the market. Consumers are increasingly looking for products that are made with natural ingredients and that have a positive impact on their health.

• Certain B. subtilis strains are recognized as safe for food use by regulatory authorities. 60% of probiotic products in the market now incorporate Bacillus subtilis strains due to this approval.
• Bacillus subtilis is widely used as a biocontrol agent in agriculture. Surveys show that over 70% of farmers applying microbial products use B. subtilis-based solutions.

Growing awareness about its health benefits to result in the expansion of the market

In recent years, there has been growing awareness about the health benefits of Bacillus subtilis. This is due to a number of factors, including the increasing number of scientific studies that have shown the benefits, the growing popularity of probiotics, and the increasing awareness of the importance of gut health. It has a number of health benefits, including improved gut health, reduced risk of infections, enhanced immunity, improved digestion, reduced inflammation, increased energy levels. The growing awareness about its health benefits is driving the growth of the market. Consumers are increasingly looking for products that can help them to improve their health, and it is one of the most promising natural health supplements available.

Restraining Factors

Stringent regulatory requirements to hamper the market growth

The market is subject to stringent regulatory requirements. This is because Bacillus subtilis is a living organism, and there are concerns about the safety of using it in products. The regulatory requirements vary from country to country. In the United States, the FDA regulates the use of it in food and dietary supplements. In Europe, the European Food Safety Authority (EFSA) regulates the use of it in food. The stringent regulatory requirements can make it difficult and expensive to bring Bacillus subtilis-based products to market.

• In some countries, stringent microbial product regulations delay approvals. Approximately 40% of new Bacillus subtilis product applications face extended review periods before commercialization.
• Environmental studies show that around 35% of Bacillus subtilis applications require additional safety evaluation before large-scale deployment.
• Download Free Sample to learn more about this report

•  

Bacillus Subtilis Market Regional Insights

Europe to lead the market owing to the increasing popularity of probiotics

The Europe region has shown the highest Bacillus subtilis market growth. The growth of the European market is driven by a number of factors, including increasing demand for natural and organic products, growing awareness about the health benefits, increasing number of scientific studies, increasing popularity of probiotics, increasing awareness of the importance of gut health.

Key Industry Players

Key players are employing advanced technologies in order to stimulate further growth of the market

All the major players are motivated to offer superior and more advanced services in order to gain a competitive edge in the market. To increase their market presence, vendors are using a variety of techniques, including product launches, regional growth, strategic alliances, partnerships, mergers, and acquisitions.

• Bayer: Approximately 70% of U.S. farmers using microbial fungicides rely on Bayer’s B. subtilis-based products.
• BASF: Over 60% of BASF’s microbial product applications have been approved or are under active review by regulatory authorities.

LIST OF TOP BACILLUS SUBTILIS COMPANIES

• Bayer: Leverkusen, Germany
• Basf: Ludwigshafen, Germany
• Qunlin: Qunlin, China
• Jocanima: Madrid, Spain
• Tonglu Huifeng: Tonglu, China
• Kernel Bio-tech: Xiamen, China
• Wuhan Nature’s Favour: Wuhan, China
• Agrilife: College Station, Texas, USA
• Real IPM: Bangalore, India
• ECOT China: Beijing, China

Report Coverage

This report examines an understanding of the Bacillus subtilis market’s size, share, growth rate, segmentation by type, application, key players, and previous and current market scenarios. The report also collects the market’s precise data and forecasts by market experts. Also, it describes the study of this industry’s financial performance, investments, growth, innovation marks, and new product launches by the top companies and offers deep insights into the current market structure, competitive analysis based on key players, key driving forces, and restraints that affect the demand for growth, opportunities, and risks.

Furthermore, the post-COVID-19 pandemic’s effects on international market restrictions and a deep understanding of how the industry will recover, and strategies are also stated in the report. The competitive landscape has also been examined in detail to provide clarification of the competitive landscape.

This report also discloses the research based on methodologies that define price trend analysis of target companies, collection of data, statistics, target competitors, import-export, information, and previous years’ records based on market sales. Moreover, all the significant factors which influence the market such as small or medium business industry, macro-economic indicators, value chain analysis, and demand-side dynamics, with all the major business players have been explained in detail. This analysis is subject to modification if the key players and feasible analysis of market dynamics change.